Primary Care Clinics in Huntington, IN Accepting Medicare
7 Primary Care Clinics found. Showing 1 - 7
 Family Practice Associates, Llp Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 2003 Stults Rd, Suite 100, Huntington, IN 46750 Phone: 260-356-5424 Fax: 260-358-2090 |
Huntington Medical Group Pc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1601 N Jefferson St, Huntington, IN 46750 Phone: 260-356-4005 Fax: 260-356-3501 |
Parkview Physicians Group Family Practice Associates Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2003 Stults Rd Ste 100, Huntington, IN 46750 Phone: 260-356-5424 Fax: 260-358-2090 |
Cardinal Family Medicine Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 225 Hauenstein Rd, Huntington, IN 46750 Phone: 630-740-5555 |
Everside Health, Llc Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 200 Noll Plz, Huntington, IN 46750 Phone: 260-355-2355 Fax: 260-355-2352 |
C. Bryan Wait, M.d., Internal Medicine, P.c. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2003 Stults Rd, John B. Kay Mob, Suite 110, Huntington, IN 46750 Phone: 260-244-0238 Fax: 260-244-1976 |
Qhg Of Fort Wayne Company Llc General Practice Medicare: Not Enrolled in Medicare Practice Location: 1415 Flaxmill Rd, Huntington, IN 46750 Phone: 260-359-1250 |
News Archive
IV-administered ketamine effective in patients with chronic PTSD
For the first time, evidence that a single dose of IV-administered ketamine was associated with the rapid reduction of symptoms of post-traumatic stress disorder in patients with chronic PTSD was demonstrated in a proof-of-concept, randomized, double blind crossover study, undertaken by researchers at the Icahn School of Medicine at Mount Sinai in New York City. These findings, according to Mount Sinai researchers, could be the first step toward developing new interventions for PTSD.
Molecular Health enters into license agreement to supply SafetyMAP software to FDA
Molecular Health has entered into a commercial license to provide the FDA with use of its SafetyMAP software - formally known as Molecular Analysis of Side Effect information (MASE), to provide a comprehensive and dynamic analytical solution for the detection and molecular analysis of drug-induced adverse events for all marketed drugs and for predicting safety issues of new drug candidates.
Adimab announces initiation of research collaboration with Novartis
Adimab, Inc., a leader in the discovery of fully human antibodies, today announced the initiation of a research collaboration with Novartis (Basel, Switzerland). This agreement represents the fifth major partnership Adimab has announced since launching its platform at BIO 2009 in Atlanta, just one year ago. In addition, Adimab today announced the receipt of a second milestone payment from its ongoing collaboration with Merck and Co.
Parkinson's patients who show depression symptoms may actually have demoralization, study says
People with Parkinson's disease who show signs of depression may actually have a condition called demoralization, according to a study published in the April 4, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology. That study found demoralization may be common in Parkinson's disease.
Study reveals key role of macrophages in systemic sclerosis
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.
› Verified 1 days ago